![Hoko Yamashita](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hoko Yamashita
Direttore/Membro del Consiglio presso Japan BCG Laboratory KK
Posizioni attive di Hoko Yamashita
Società | Posizione | Inizio | Fine |
---|---|---|---|
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Hoko Yamashita
Statistiche
Distribuzione geografica
Giappone | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Hoko Yamashita
- Esperienza